322 related articles for article (PubMed ID: 25578828)
1. Solid lipid nanoparticles as nucleic acid delivery system: properties and molecular mechanisms.
de Jesus MB; Zuhorn IS
J Control Release; 2015 Mar; 201():1-13. PubMed ID: 25578828
[TBL] [Abstract][Full Text] [Related]
2. How cationic lipids transfer nucleic acids into cells and across cellular membranes: recent advances.
Rehman Zu; Zuhorn IS; Hoekstra D
J Control Release; 2013 Feb; 166(1):46-56. PubMed ID: 23266451
[TBL] [Abstract][Full Text] [Related]
3. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.
Choi SH; Jin SE; Lee MK; Lim SJ; Park JS; Kim BG; Ahn WS; Kim CK
Eur J Pharm Biopharm; 2008 Mar; 68(3):545-54. PubMed ID: 17881199
[TBL] [Abstract][Full Text] [Related]
4. A new optimized formulation of cationic solid lipid nanoparticles intended for gene delivery: development, characterization and DNA binding efficiency of TCERG1 expression plasmid.
Fàbregas A; Sánchez-Hernández N; Ticó JR; García-Montoya E; Pérez-Lozano P; Suñé-Negre JM; Hernández-Munain C; Suñé C; Miñarro M
Int J Pharm; 2014 Oct; 473(1-2):270-9. PubMed ID: 24999055
[TBL] [Abstract][Full Text] [Related]
5. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid.
Vighi E; Ruozi B; Montanari M; Battini R; Leo E
Eur J Pharm Biopharm; 2007 Sep; 67(2):320-8. PubMed ID: 17368876
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles: promising therapeutic nanocarriers for drug delivery.
Thukral DK; Dumoga S; Mishra AK
Curr Drug Deliv; 2014; 11(6):771-91. PubMed ID: 25469779
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticles as delivery systems for Gambogenic acid.
Huang X; Chen YJ; Peng DY; Li QL; Wang XS; Wang DL; Chen WD
Colloids Surf B Biointerfaces; 2013 Feb; 102():391-7. PubMed ID: 23010123
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of an improved formulation of cholesteryl oleate-loaded cationic solid-lipid nanoparticles as an efficient non-viral gene delivery system.
Limeres MJ; Suñé-Pou M; Prieto-Sánchez S; Moreno-Castro C; Nusblat AD; Hernández-Munain C; Castro GR; Suñé C; Suñé-Negre JM; Cuestas ML
Colloids Surf B Biointerfaces; 2019 Dec; 184():110533. PubMed ID: 31593829
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles as vehicles for macromolecules: nucleic acids and peptides.
del Pozo-Rodríguez A; Delgado D; Solinís MA; Gascón AR
Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):214-26. PubMed ID: 21834776
[TBL] [Abstract][Full Text] [Related]
10. Lipid Nanoparticles as Potential Gene Therapeutic Delivery Systems for Oral Administration.
Dorraj G; Carreras JJ; Nunez H; Abushammala I; Melero A
Curr Gene Ther; 2017; 17(2):89-104. PubMed ID: 28494737
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles for ocular drug delivery.
Seyfoddin A; Shaw J; Al-Kassas R
Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
[TBL] [Abstract][Full Text] [Related]
12. Lipid Nanoparticles for Cell-Specific in Vivo Targeted Delivery of Nucleic Acids.
Khalil IA; Younis MA; Kimura S; Harashima H
Biol Pharm Bull; 2020; 43(4):584-595. PubMed ID: 32238701
[TBL] [Abstract][Full Text] [Related]
13. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
Harde H; Das M; Jain S
Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
[TBL] [Abstract][Full Text] [Related]
14. Lipid nanoparticles as drug/gene delivery systems to the retina.
del Pozo-Rodríguez A; Delgado D; Gascón AR; Solinís MÁ
J Ocul Pharmacol Ther; 2013 Mar; 29(2):173-88. PubMed ID: 23286300
[TBL] [Abstract][Full Text] [Related]
15. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
16. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation.
Clares B; Calpena AC; Parra A; Abrego G; Alvarado H; Fangueiro JF; Souto EB
Int J Pharm; 2014 Oct; 473(1-2):591-8. PubMed ID: 25102113
[TBL] [Abstract][Full Text] [Related]
17. A promising targeted gene delivery system: folate-modified dexamethasone-conjugated solid lipid nanoparticles.
Wang W; Zhou F; Ge L; Liu X; Kong F
Pharm Biol; 2014 Aug; 52(8):1039-44. PubMed ID: 24611745
[TBL] [Abstract][Full Text] [Related]
18. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release.
Souza LG; Silva EJ; Martins AL; Mota MF; Braga RC; Lima EM; Valadares MC; Taveira SF; Marreto RN
Eur J Pharm Biopharm; 2011 Sep; 79(1):189-96. PubMed ID: 21352915
[TBL] [Abstract][Full Text] [Related]
19. Solid lipid nanoparticles as drug delivery systems.
Manjunath K; Reddy JS; Venkateswarlu V
Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):127-44. PubMed ID: 15834465
[TBL] [Abstract][Full Text] [Related]
20. Cationic lipid nanosystems as carriers for nucleic acids.
Cortesi R; Campioni M; Ravani L; Drechsler M; Pinotti M; Esposito E
N Biotechnol; 2014 Jan; 31(1):44-54. PubMed ID: 24120492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
